2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations

被引:34
作者
Zeitouni, Michel [1 ]
Sabouret, Pierre [1 ]
Kerneis, Mathieu [1 ]
Silvain, Johanne [1 ]
Collet, Jean-Philippe [1 ]
Bruckert, Eric [2 ,3 ]
Montalescot, Gilles [1 ]
机构
[1] Sorbonne Univ, Inst Cardiol, APHP, Dept Cardiol,ACTION Study Grp,INSERM,UMRS_1166, 47-83 Bld Hop, F-75013 Paris, France
[2] Sorbonne Univ, Cardio Metab Inst, 83 Bld Hop, F-75013 Paris, France
[3] Sorbonne Univ, Pitie Salpetriere Hosp, Dept Endocrinol, 83 Bld Hop, F-75013 Paris, France
关键词
Dyslipidaemia; Guidelines; Statins; PCSSK9; inhibitors; CORONARY-HEART-DISEASE; CHOLESTEROL EFFLUX CAPACITY; JOINT TASK-FORCE; CARDIOVASCULAR-DISEASE; LDL CHOLESTEROL; STATIN THERAPY; HIGH-RISK; MYOCARDIAL-INFARCTION; EUROPEAN GUIDELINES; METABOLIC SYNDROME;
D O I
10.1093/ehjcvp/pvaa077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 2019, the European Society of Cardiology and European Atherosclerosis Society released a new guideline document with substantial changes regarding the assessment of cardiovascular risk and treatments. The update of high-risk criteria and categories led to a better detection and primary prevention of patients at risk of a first cardiovascular event. Nonetheless, additional efforts are needed for a better inclusion of risk modifiers, especially specific to women, to improve risk stratification and direct primary prevention. Eventually, we discuss how these new guidelines implement PCSK9 inhibitors for very high-risk individuals and the evidence supporting new low-density lipoprotein cholesterol goals below, such as 55 and 40 mg/dL.
引用
收藏
页码:324 / 333
页数:10
相关论文
共 64 条
[1]   Incidence and outcome of first myocardial infarction according to gender and age in Denmark over a 35-year period (1978-2012) [J].
Alzuhairi, Karam Sadoon ;
Sogaard, Peter ;
Ravkilde, Jan ;
Gislason, Gunnar ;
Kober, Lars ;
Torp-Pedersen, Christian .
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2015, 1 (02) :72-78
[2]   A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke [J].
Amarenco, P. ;
Kim, J. S. ;
Labreuche, J. ;
Charles, H. ;
Abtan, J. ;
Bejot, Y. ;
Cabrejo, L. ;
Cha, J-K ;
Ducrocq, G. ;
Giroud, M. ;
Guidoux, C. ;
Hobeanu, C. ;
Kim, Y. J. ;
Lapergue, B. ;
Lavallee, P. C. ;
Lee, B-C ;
Lee, K-B ;
Leys, D. ;
Mahagne, M-H ;
Meseguer, E. ;
Nighoghossian, N. ;
Pico, F. ;
Samson, Y. ;
Sibon, I ;
Steg, P. G. ;
Sung, S-M ;
Touboul, P. J. ;
Touze, E. ;
Varenne, O. ;
Vicaut, E. ;
Yelles, N. ;
Bruckert, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :9-19
[3]   Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction The ARIC Community Surveillance Study [J].
Arora, Sameer ;
Stouffer, George A. ;
Kucharska-Newton, Anna M. ;
Qamar, Arman ;
Vaduganathan, Muthiah ;
Pandey, Ambarish ;
Porterfield, Deborah ;
Blankstein, Ron ;
Rosamond, Wayne D. ;
Bhatt, Deepak L. ;
Caughey, Melissa C. .
CIRCULATION, 2019, 139 (08) :1047-1056
[4]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[5]   Effects of torcetrapib in patients at high risk for coronary events [J].
Barter, Philip J. ;
Caulfield, Mark ;
Eriksson, Mats ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Komajda, Michel ;
Lopez-Sendon, Jose ;
Mosca, Lori ;
Tardif, Jean-Claude ;
Waters, David D. ;
Shear, Charles L. ;
Revkin, James H. ;
Buhr, Kevin A. ;
Fisher, Marian R. ;
Tall, Alan R. ;
Brewer, Bryan .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122
[6]   Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia [J].
Bhatt, Deepak L. ;
Steg, P. Gabriel ;
Miller, Michael ;
Brinton, Eliot A. ;
Jacobson, Terry A. ;
Ketchum, Steven B. ;
Doyle, Ralph T., Jr. ;
Juliano, Rebecca A. ;
Jiao, Lixia ;
Granowitz, Craig ;
Tardif, Jean-Claude ;
Ballantyne, Christie M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01) :11-22
[7]   Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome [J].
Bittner, Vera A. ;
Szarek, Michael ;
Aylward, Philip E. ;
Bhatt, Deepak L. ;
Diaz, Rafael ;
Edelberg, Jay M. ;
Fras, Zlatko ;
Goodman, Shaun G. ;
Halvorsen, Sigrun ;
Hanotin, Corinne ;
Harrington, Robert A. ;
Jukema, J. Wouter ;
Loizeau, Virginie ;
Moriarty, Patrick M. ;
Moryusef, Angele ;
Pordy, Robert ;
Roe, Matthew T. ;
Sinnaeve, Peter ;
Tsimikas, Sotirios ;
Vogel, Robert ;
White, Harvey D. ;
Zahger, Doron ;
Zeiher, Andreas M. ;
Steg, Gabriel ;
Schwartz, Gregory G. ;
Aylward, Philip E. ;
Drexel, Heinz ;
Sinnaeve, Peter ;
Dilic, Mirza ;
Lopes, Renato D. ;
Gotcheva, Nina N. ;
Prieto, Juan-Carlos ;
Yong, Huo ;
Lopez-Jaramillo, Patricio ;
Pecin, Ivan ;
Reiner, Zeljko ;
Ostadal, Petr ;
Poulsen, Steen Hvitfeldt ;
Viigimaa, Margus ;
Nieminen, Markku S. ;
Danchin, Nicolas ;
Chumburidze, Vakhtang ;
Marx, Nikolaus ;
Liberopoulos, Evangelos ;
Montenegro Valdovinos, Pablo Carlos ;
Tse, Hung-Fat ;
Kiss, Robert Gabor ;
Xavier, Denis ;
Zahger, Doron ;
Valgimigli, Marco .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (02) :133-144
[8]   Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study [J].
Blaha, Michael J. ;
Budoff, Matthew J. ;
DeFilippis, Andrew P. ;
Blankstein, Ron ;
Rivera, Juan J. ;
Agatston, Arthur ;
O'Leary, Daniel H. ;
Lima, Joao ;
Blumenthal, Roger S. ;
Nasir, Khurram .
LANCET, 2011, 378 (9792) :684-692
[9]   Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) [J].
Budoff, Matthew J. ;
Young, Rebekah ;
Burke, Gregory ;
Carr, J. Jeffrey ;
Detrano, Robert C. ;
Folsom, Aaron R. ;
Kronmal, Richard ;
Lima, Joao A. C. ;
Liu, Kiang J. ;
McClelland, Robyn L. ;
Michos, Erin ;
Post, Wendy S. ;
Shea, Steven ;
Watson, Karol E. ;
Wong, Nathan D. .
EUROPEAN HEART JOURNAL, 2018, 39 (25) :2401-+
[10]   Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].
Cannon, Christopher P. ;
Blazing, Michael A. ;
Giugliano, Robert P. ;
McCagg, Amy ;
White, Jennifer A. ;
Theroux, Pierre ;
Darius, Harald ;
Lewis, Basil S. ;
Ophuis, Ton Oude ;
Jukema, J. Wouter ;
De Ferrari, Gaetano M. ;
Ruzyllo, Witold ;
De Lucca, Paul ;
Im, KyungAh ;
Bohula, Erin A. ;
Reist, Craig ;
Wiviott, Stephen D. ;
Tershakovec, Andrew M. ;
Musliner, Thomas A. ;
Braunwald, Eugene ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397